Literature DB >> 1621971

31P NMR analysis of red blood cell UDPGlucose and UDPGalactose: comparison with HPLC and enzymatic methods.

S L Wehrli1, M J Palmieri, G T Berry, H N Kirkman, S Segal.   

Abstract

The levels of uridine diphosphogalactose (UDPGal) and uridine diphosphoglucose (UDPGlu) in trichloroacetic acid extracts of human red blood cells (RBC) were measured by 31P NMR spectroscopy. Individual determinations were compared to results obtained by enzymatic and high-pressure liquid chromatographic (HPLC) methods. The characteristic doublet of the P beta resonance signals of both UDPGal and UDPGlu were detected in proton-decoupled spectra of extracts. Quantitative analyses were obtained by employing a standard, methylene diphosphonate, in an external capillary tube during data acquisition for periods of 14 to 24 h using an "inverse-gated" pulse sequence. The ratio of the integrated area of each of the uridine sugar nucleotide doublets to the area of the external reference peak was linear with concentrations between 0.03 and 0.50 mM. There was no difference between the mean value obtained by 31P NMR of 6.6 +/- 1.4 mumol UDPGlu/100 g Hgb or 2.1 +/- 0.6 mumol UDPGal/100 gHgb and the corresponding levels determined enzymatically or by HPLC in identical RBC extracts. When analyzed as paired data, only UDPGlu by NMR was found to be lower than the value obtained by HPLC. As a quantitative analytical tool, NMR spectrometry validated both the enzymatic and HPLC methods used for measurement of uridine sugar nucleotides in our laboratories.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621971     DOI: 10.1016/0003-2697(92)90214-r

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  10 in total

1.  Estimates of uridine diphosphate glucose in human erythrocytes.

Authors:  H N Kirkman
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Komrower Lecture. Galactosaemia today: the enigma and the challenge.

Authors:  S Segal
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

3.  Quantitative measurement of redox state in human brain by 31 P MRS at 7T with spectral simplification and inclusion of multiple nucleotide sugar components in data analysis.

Authors:  Jimin Ren; Craig R Malloy; A Dean Sherry
Journal:  Magn Reson Med       Date:  2020-05-09       Impact factor: 4.668

4.  Oxidation of galactose by galactose-1-phosphate uridyltransferase-deficient lymphoblasts.

Authors:  C Yager; J Gibson; B States; L J Elsas; S Segal
Journal:  J Inherit Metab Dis       Date:  2001-08       Impact factor: 4.982

5.  Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.

Authors:  Sang-Young Kim; Bruce M Cohen; Xi Chen; Scott E Lukas; Ann K Shinn; A Cagri Yuksel; Tao Li; Fei Du; Dost Öngür
Journal:  Schizophr Bull       Date:  2016-09-24       Impact factor: 9.306

6.  UDP-glucose and UDP-galactose concentrations in cultured skin fibroblasts of patients with classical galactosaemia.

Authors:  N J Keevill; J B Holton; J T Allen
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 7.  Defective galactosylation in galactosemia: is low cell UDPgalactose an explanation?

Authors:  S Segal
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 8.  Measurements of uridine diphosphate glucose and uridine diphosphate galactose--an appraisal.

Authors:  H N Kirkman
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

9.  On the stability of nucleoside diphosphate glucose metabolites: implications for studies of plant carbohydrate metabolism.

Authors:  Benjamin L Hill; Carlos M Figueroa; Matías D Asencion Diez; John E Lunn; Alberto A Iglesias; Miguel A Ballicora
Journal:  J Exp Bot       Date:  2017-06-15       Impact factor: 6.992

10.  In vivo 31P magnetic resonance spectroscopy study of mouse cerebral NAD content and redox state during neurodevelopment.

Authors:  Radek Skupienski; Kim Q Do; Lijing Xin
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.